| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/23/2008 | CN101224284A Compounds for treating Hepatitis B and preparing method thereof |
| 07/23/2008 | CN101224281A Chinese traditional medicine preparation for relieving heat and toxins |
| 07/23/2008 | CN101224279A Medicine compound for treating urinary infection and preparing method thereof |
| 07/23/2008 | CN101224252A External Chinese patent medicine for treating tinea |
| 07/23/2008 | CN101224244A Children clearing heat suppository and preparing method thereof |
| 07/23/2008 | CN101224235A Treating eperythrozoonosis medicine, preparing method and uses thereof |
| 07/23/2008 | CN101224225A Preparing method of hypericum perforatum extract |
| 07/23/2008 | CN101224217A Skeleton type roxithromycin sustained release pellet capsule |
| 07/23/2008 | CN101224214A External coating liquid for treating erysipelas, carbuncle, scabies, eczema, hives |
| 07/23/2008 | CN101224213A External coating liquid for treating various fungi, ringworm, ichthyosis, psoriasis |
| 07/23/2008 | CN101224211A Entecavir solid dispersoid, medicine compounds and preparing method and applications thereof |
| 07/23/2008 | CN101224209A Novel anti- hepatitis B virus medicine compounds-lamivudine and protocatechuic acid |
| 07/23/2008 | CN101224195A Compounding method of cefpirome sulfate raw material and uses thereof |
| 07/23/2008 | CN100404677C Method for producing recombinant interleukin for animal |
| 07/23/2008 | CN100404669C Novel reovirus, its antibody and vaccine and use thereof |
| 07/23/2008 | CN100404662C Novel antiretroviral sulpholipids extracted from spirulinae, method for obtaining same, compositions containing same and use thereof as inhibitors of the HIV virus reverse transcriptase |
| 07/23/2008 | CN100404557C Preparation method of umbellate pore fungus polysaccharide sulphate |
| 07/23/2008 | CN100404554C Antifish lymphocystis virus capsid protein monoclonal antibody, and its preparing method |
| 07/23/2008 | CN100404550C Gene MgPTH12 for controlling mature and pathogenicity of fungi appressorium derived from Magnaporthe grisea and its uses |
| 07/23/2008 | CN100404527C Chiral 4,4'-dimethoxy-5,6,5',6'-bis methylene dioxy -2,2'-phthalic acid derivatives and process for preparing same |
| 07/23/2008 | CN100404521C Compound separated from petroleum ether extract of glycyrrhiza legume bacteria strain CCNWGX022 fermentation liquid |
| 07/23/2008 | CN100404489C Method for extracting hypericin |
| 07/23/2008 | CN100404073C Method for preparing hard-soluble gel formulation |
| 07/23/2008 | CN100404070C Packaged virus-like particles |
| 07/23/2008 | CN100404064C Medicine composition having functions of resisting virus and clearing heat and preparing method |
| 07/23/2008 | CN100404062C Powder for treating beriberi and preparation method thereof |
| 07/23/2008 | CN100404054C Decoction Chinese medicine sterilizing antiphlogistic, preparation and use thereof |
| 07/23/2008 | CN100404046C Antiseptic for preventing and treating tinea unguium and tinea of feet and hands |
| 07/23/2008 | CN100404045C Hepatitis B treating medicine and its preparing method |
| 07/23/2008 | CN100404031C Soft capsule composition containing zine gluconate, Ibuprofen and chlorphenamine maleate |
| 07/23/2008 | CN100404030C Application of leflunomide in the preparation process of anti SARS virus medicine |
| 07/23/2008 | CN100404029C Use of geldanamycin ú¿C-3559ú®in preparing drug for herpesvirus genital tract affection |
| 07/23/2008 | CN100404019C Multivesicular emulsion topical delivery systems |
| 07/22/2008 | US7402683 Cinnamic acid amides |
| 07/22/2008 | US7402655 Nucleotide sequences coding polypeptide for use in the treatment of canccer, inflamation and infectious disorders |
| 07/22/2008 | US7402600 Nitroderivatives of cardiovascular agents |
| 07/22/2008 | US7402580 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 07/22/2008 | US7402577 Androstane 17-beta-carboxamides as androgen receptor modulators |
| 07/22/2008 | US7402575 Methods of treating inflammation |
| 07/22/2008 | US7402572 Suppressing a symptom of an allergic response using nucleic acids containing unmethylated CpG dinucleotides |
| 07/22/2008 | US7402569 Combining such as sulforaphane with glucosinolate component; economical food additive or dietary supplement |
| 07/22/2008 | US7402324 Process for preparing aqueous extracts of plants and extracts so obtained |
| 07/22/2008 | US7402318 Medical devices having antimicrobial coatings thereon |
| 07/22/2008 | US7402315 Peptide of given sequence; fused to glutathione-S-transferase; use in immunoassays and vaccines |
| 07/22/2008 | US7402305 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/22/2008 | US7402304 human granulocyte colony stimulating factor polypeptides having amino acid replacements in the sequence, used for treating hematopoietic, neurological or reproductive disorders |
| 07/22/2008 | US7402299 Intracorporeal medicaments for photodynamic treatment of disease |
| 07/22/2008 | CA2388076C Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 07/22/2008 | CA2372270C C-2 modified erythromycin derivatives |
| 07/22/2008 | CA2313638C Cyclohexene carboxylates as neuraminidase inhibitors |
| 07/22/2008 | CA2283420C Lyme disease antigen compositions and uses |
| 07/22/2008 | CA2280773C Methods for the administration of amifostine |
| 07/22/2008 | CA2278328C Antifungal nail lacquer and method using same |
| 07/22/2008 | CA2272466C Compositions containing an antifungal and a phospholipid |
| 07/22/2008 | CA2271008C Acellular pertussis vaccine with diphtheria- and tetanus-toxoids |
| 07/22/2008 | CA2238661C Killer t cell activator and use thereof |
| 07/17/2008 | WO2008086529A2 Compositions and methods for targeted inactivation of hiv cell surface receptors |
| 07/17/2008 | WO2008084710A1 Inhibitor of herpesvirus infection, method for inhibition of herpesvirus infection, and use thereof |
| 07/17/2008 | WO2008084561A1 HELICOBACTER PYLORI GROWTH INHIBITOR CONTAINING α-N-ACETYLGLUCOSAMINYL-BINDING MONOSACCHARIDE DERIVATIVE |
| 07/17/2008 | WO2008084504A2 Pharmaceutical compositions of angiotensin ii receptor blockers |
| 07/17/2008 | WO2008083561A1 Oral pharmaceutical composition of glycyrrhizin or its salts and the preparation method thereof |
| 07/17/2008 | WO2008083432A1 Recombinant antibodies |
| 07/17/2008 | WO2008063957A3 Cblb for treating endotoxin-mediated disorders |
| 07/17/2008 | WO2008062379A3 4- (2-oxo-oxazolidin-3yl)-phenoxymethyle derivativeas as antibacterials |
| 07/17/2008 | WO2008062379A2 4- (2-oxo-oxazolidin-3yl)-phenoxymethyle derivativeas as antibacterials |
| 07/17/2008 | WO2008051244A3 Anthranilic acid derivatives useful in treating infection with hepatitis c virus |
| 07/17/2008 | WO2007146039A3 Crystalline forms of n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl] thio]-2-thiazolyl]-4-piperidinecarboxamide |
| 07/17/2008 | WO2007123868A3 Organic thiophosphate antiretroviral agents |
| 07/17/2008 | WO2007117337A3 Development of novel antibiotic alternatives |
| 07/17/2008 | WO2007101264A3 Method for treating endothelial and epithelial cell disorders by administering high molecular weight peg-like compounds |
| 07/17/2008 | WO2007057763A3 Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant |
| 07/17/2008 | US20080171871 2,2-Dichloro-N-[2-[3-(2-chloro-6-fluorophenyl)-5-isoxazolyl]-(4-pyridyl)]Acetamide; Hepatitis C virus |
| 07/17/2008 | US20080171862 Double stranded RNA packaged in liposome for use therapeutic tool in treatment of cell proliferative and viral disorders; Antisense oligonucleotide for use in prevention and treatment of viral and tumor disorders; gene expression inhibition; RNA interference |
| 07/17/2008 | US20080171861 Method and medicament for inhibiting the expression of a given gene |
| 07/17/2008 | US20080171766 Administering pleuromutilin derivative for treatment/prophylaxis of infection caused by antimicrobial resistant bacteria |
| 07/17/2008 | US20080171763 Compounds and methods for treatment and prevention of diseases |
| 07/17/2008 | US20080171724 Phosphonate Derivatives of Mycophenolic Acid |
| 07/17/2008 | US20080171706 Anti-Adhesive Compounds to Prevent and Treat Bacterial Infections |
| 07/17/2008 | US20080171106 Exposing probiotic to a gastric juice; providing a model of a pet small intestine;introducing the probiotic and a pathogen into the model;measuring anti-pathogenic metabolite produced by probiotic; andusing the identified probiotic to produce a pet food |
| 07/17/2008 | US20080171097 Synergistic mixture of licorice root extract and oak bark and dexpanthenol; treatment of herpes virus and microorganism caused diseases; cosmetics, foods |
| 07/17/2008 | US20080171079 Administering an immunogenic composition of Varicella-Zoster Virus gE, or immunogenic fragment, and a TH-1 adjuvant |
| 07/17/2008 | US20080171063 Multivalent influenza vaccine in an oil-in-water emulsion of a metabolizable oil (squalene), a sterol and an emulsifier; includes pandemic strains such as H5N1, H9N2, H7N7, H2N2 and H1N1 |
| 07/17/2008 | US20080171060 Lymphocyte receptor peptide for use in prevention and treatment of viral infection, cell proliferative, cardiovascular and allergic disorders; enhancing cytokine production |
| 07/17/2008 | US20080171055 Using blood brain barrier receptor specific immunoglobullin as diagnostic and therapeutic for prevention, detection treatment of brain disorders |
| 07/17/2008 | US20080171054 Immunoglobulin for use in detection, prevention and treatment of methicillin-resistant staphylococcus aureus (MRSA) infection |
| 07/17/2008 | US20080171050 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 07/17/2008 | US20080171046 Novel proteins and nucleic acids encoding same |
| 07/17/2008 | US20080171021 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 07/17/2008 | US20080171017 Therapeutic mixture comprising chimeric interleukin receptor, microbiocidal, antiproliferative and chemotherapeutic agent for use in treatment and prevention of infectious and cancer disorders |
| 07/17/2008 | US20080171015 Compounds for the Treatment of Hepatitis C |
| 07/17/2008 | US20080171014 Interleukin-13 binding proteins |
| 07/17/2008 | US20080170996 Administering a microbial lysate by aerosol inhalation; for immunocomprised patients, enhancing innate immunity, attenuate respiratory infection |
| 07/17/2008 | DE102007002170A1 Produkt Süßholzwurzel + Eichenrinde in Kombination mit Dexpanthenol Product licorice root + oak bark in combination with dexpanthenol |
| 07/17/2008 | CA2673755A1 Human cytomegalovirus neutralising antibodies and use thereof |
| 07/16/2008 | EP1944371A2 Neisseria meningitidis antigens and compositions |
| 07/16/2008 | EP1944303A1 Pyridine derivative substituted by heterocycle and fungicide containing the same |
| 07/16/2008 | EP1944300A2 Prodrugs of aspartyl protease inhibitors |
| 07/16/2008 | EP1944036A2 Improvements in and relating to drug delivery |
| 07/16/2008 | EP1944033A2 Use of pectin hydrolysis products |
| 07/16/2008 | EP1944023A1 Product of liquorice root and oak rinds combined with dexpanthenol |